Antigenics, Inc.
🏢 View company profile →11Patents
4Active
11Granted
37Portfolio score
Filing activity: Aug 28, 1998 → Jun 25, 2012 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7049302B1 | Compositions of CPG and saponin adjuvants and uses thereof | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6524584B2 | Saponin compositions and uses thereof | Human Necessities | 26 | Expired |
| US6645495B1 | Compositions of saponin adjuvants and excipients | Human Necessities | 23 | Expired |
| US7858589B2 | Compositions of CpG and saponin adjuvants and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US8093008B2 | Characterization of granulocytic ehrlichia and methods of use | Emerging Cross-Sectional Technologies | 7 | Active |
| US7309491B2 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8435495B2 | Characterization of granulocytic Ehrlichia and methods of use | Emerging Cross-Sectional Technologies | 5 | Active |
| US7863434B2 | Characterization of granulocytic Ehrlichia and methods of use | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7420037B2 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8461323B2 | Characterization of granulocytic ehrlichia and methods of use | Emerging Cross-Sectional Technologies | 2 | Active |
| US7030094B2 | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.